We have moved Medical technologies guidance 40 to become HealthTech guidance 495. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment ...
Having considered the various meta-analyses done by the EAC, the committee preferred the meta-analysis of the 3 randomised controlled trials and concluded that any benefit provided by Mepilex Border ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results